This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.
Here is a sample of this item:
by Stockwatch Business Reporter
Amid a broader market increase, the S&P/TSX Cannabis Index gained 1.37 points to 137.21 Wednesday, while the Canadian Securities Exchange Composite Index gained 7.09 points to 320.23. In company news, United States-based Abacus Health Products Inc. (ABCS) gained 27 cents to $4.75 on 67,300 shares after releasing its fourth quarter and full-year results for 2019. Before getting to its results, Abacus highlighted its March 23 agreement to be acquired by fellow CBD producer Charlotte's Web Holdings Inc. (CWEB: $6.57) in a deal that valued Abacus at about $99-million.
Charlotte's Web's main product is CBD gummies, while Abacus tends to sell more typical products, such as CBD oil, ointments and sprays. Under the deal, Abacus shareholders would receive 0.85 of a Charlotte's Web share for each Abacus share held. Abacus says it expects the deal to close in Q2 but, given the long regulatory processes for other cannabis-related acquisitions in the U.S., investors will not be holding their breath.
The remainder is available to Stockwatch subscribers.
© 2020 Canjex Publishing Ltd. All rights reserved.